Cigna Group — Director's Dealing 2021

Jan 8, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cigna Corp (CI)
CIK: 0001739940
Period of Report: 2021-01-06

Reporting Person: Miller Steven B (EVP, Chief Clinical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-06	Common Stock, $.01 Par Value	M	8972.0000	$160.6623	Acquired	35076.0000	Direct
2021-01-06	Common Stock, $.01 Par Value	S	8972.0000	$210.0000	Disposed	26104.0000	Direct
2021-01-07	Common Stock, $.01 Par Value	M	777.0000	$160.6623	Acquired	26881.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-06	Employee Stock Option (Right to Buy)	$160.6623	M	8972.0000	Disposed	2021-03-05	Common Stock, $.01 Par Value (8972.0000)	Direct
2021-01-07	Employee Stock Option (Right to Buy)	$160.6623	M	777.0000	Disposed	2021-03-05	Common Stock, $.01 Par Value (777.0000)	Direct

Footnotes

F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020.

F2: This option was granted on March 5, 2014. The option vested in three equal annual installments on February 28, 2015, February 28, 2016, and February 28, 2017.